Chengjia Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chengjia Li has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bing Wang
The First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China
1 shared publication - He Wang
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine a , City Harbin, Province Heilongjiang, China
1 shared publication - Huijun Chen
Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China
1 shared publication Jianfei Yang
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine a , City Harbin, Province Heilongjiang, China
1 shared publicationQiushi Suo
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine a , City Harbin, Province Heilongjiang, China
1 shared publicationRui Qie
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine a , City Harbin, Province Heilongjiang, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Cardiology Research and Practice
- Vol. 2025 (1) , 4684871
The Value of Electroacupuncture in the Treatment of Coronary Heart Disease: A Review of the Mechanisms and Clinical Studies of Electroacupuncture Therapy
Electroacupuncture (EA) therapy combines electrical stimulation with traditional acupuncture therapy and is widely used as a physical therapy in various fields. Coronary heart disease (CHD) is a prevalent cardiovascular condition. Applying EA in the treatment of CHD patients has proven to effectively enhance therapeutic outcomes and improve prognosis. This paper summarizes the potential mechanisms of EA in the treatment of CHD, its therapeutic effects on CHD patients, and analyzes the current bottlenecks in the application of EA therapy for CHD. Furthermore, it discusses potential future directions for EA in CHD management.
- 1 January 2025
- Published by Wiley in Cardiology Research and Practice
- Vol. 2025 (1) , 4684871
Open AccessThe Value of Electroacupuncture in the Treatment of Coronary Heart Disease: A Review of the Mechanisms and Clinical Studies of Electroacupuncture Therapy
Electroacupuncture (EA) therapy combines electrical stimulation with traditional acupuncture therapy and is widely used as a physical therapy in various fields. Coronary heart disease (CHD) is a prevalent cardiovascular condition. Applying EA in the treatment of CHD patients has proven to effectively enhance therapeutic outcomes and improve prognosis. This paper summarizes the potential mechanisms of EA in the treatment of CHD, its therapeutic effects on CHD patients, and analyzes the current bottlenecks in the application of EA therapy for CHD. Furthermore, it discusses potential future directions for EA in CHD management.
- 7 October 2022
- Published by Oxford University Press (OUP) in Molecular Omics
- Vol. 18 (10) , 977-990
Ethyl acetate extract of Caesalpinia sappan L. for the treatment of atherosclerosis in ApoE−/− mice and its mechanism
The ethyl acetate extract of Caesalpinia sappan L. is a traditional Chinese medicine extract commonly used in the treatment of atherosclerosis. However, the mechanism of its use in the treatment of AS is not yet clear, which seriously affects the wide-scale application of this drug. In this study, a combination of metabolomics and lipidomics was used to analyze cardiac tissue to obtain differential metabolites and differential lipid molecules, bioinformatic analysis was performed on the significantly different metabolites and subclass analysis, cluster analysis, and chain length and chain saturation analyses were performed on screened lipid molecules showing significant differences. A correlation network diagram of the screened differential metabolites and differential lipid molecules was constructed. Hematoxylin and eosin staining of thoracic aorta in rats confirmed its therapeutic effect. This study found that the ethyl acetate extract of C. sappan L. upregulates D-mannose through the lysosome pathway, enhances lysosomal function, mediates autophagy, and indirectly regulates the levels of lipid subtypes such as lysophosphatidylinositol and phosphatidylserine, thereby improving AS.
- 7 October 2022
- Published by Oxford University Press (OUP) in Molecular Omics
- Vol. 18 (10) , 977-990
Ethyl acetate extract of Caesalpinia sappan L. for the treatment of atherosclerosis in ApoE−/− mice and its mechanism
The ethyl acetate extract of Caesalpinia sappan L. is a traditional Chinese medicine extract commonly used in the treatment of atherosclerosis. However, the mechanism of its use in the treatment of AS is not yet clear, which seriously affects the wide-scale application of this drug. In this study, a combination of metabolomics and lipidomics was used to analyze cardiac tissue to obtain differential metabolites and differential lipid molecules, bioinformatic analysis was performed on the significantly different metabolites and subclass analysis, cluster analysis, and chain length and chain saturation analyses were performed on screened lipid molecules showing significant differences. A correlation network diagram of the screened differential metabolites and differential lipid molecules was constructed. Hematoxylin and eosin staining of thoracic aorta in rats confirmed its therapeutic effect. This study found that the ethyl acetate extract of C. sappan L. upregulates D-mannose through the lysosome pathway, enhances lysosomal function, mediates autophagy, and indirectly regulates the levels of lipid subtypes such as lysophosphatidylinositol and phosphatidylserine, thereby improving AS.